$49 Wegovy Copycat Pill Sparks Selloff In Novo Shares
Just when Goldman’s long-time Novo Nordisk bull James Quigley likely thought the downside was exhausted, the stock plunged yet again on Thursday after tumbling earlier this week following a dismal sales outlook.
Shares dropped below the six-month base in the stock around the 300 kroner level after telehealth firm Hims & Hers Health rolled out a cheaper copycat version of Wegovy, delivering another blow to the beleaguered Danish drugmaker.
“Today, we’re taking the next step in personalized care by introducing a Compounded Semaglutide Pill for weight loss, with introductory plans starting at just $49 for the first month* with a 5-month plan,” HIMS wrote in a press release.
HIMS’ weight-loss pill comes shortly after Novo launched the Wegovy pill in January for $149 per month.
Last June, Novo terminated its partnership, citing the telehealth company’s “illegal mass compounding and deceptive marketing.”
On Tuesday, Novo reported a disappointing full-year outlook, warning of a tough year in the GLP-1 market. Besides HIMS, the company faces competition from Eli Lilly’s Zepbound, gaining ever-larger market share in the U.S.
Only last week, Goldman analyst Faris Mourad was telling clients that “obesity drugs narrative sentiment is on the rise” and “it’s an opportunity to buy the dip.”
Goldman’s Quigley noted, “FY26 is a reset year with respect to the pricing aspect of the GLP-1 market.”
Tyler Durden Thu, 02/05/2026 – 12:40
Source: https://freedombunker.com/2026/02/05/49-wegovy-copycat-pill-sparks-selloff-in-novo-shares/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


